// App-Quantinova.ai

P4-06-05 : Heterogeneity of DCIS does not appear to be a biomarker for development of subsequent invasive cancer

Researchers

Presenter

  • Anargyros Megalios

Principal Investigators

  • Vandna Shah

  • Rana Shami

  • Salpie Nowinski

  • Jelmar Quist

  • Mathini Sridharan

  • Carolina Salinas de Souza

  • Karen Clements

  • Anita Grigoriadis

  • Sarah Pinder

  • Alastair Thompson

  • Elinor Sawyer

Medical Centers

  • Kings College London, London, United Kingdom

  • Public Health England, Birmingham, United Kingdom

  • Baylor College of Medicine, Houston, TX

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A